Concepedia

Publication | Closed Access

The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly

DOI

62

Citations

31

References

2009

Year

Ignacio Bernabéu, Cristina Álvarez‐Escolá, Celsa Quinteiro, Tomás Lúcas, Manel Puig‐Domingo, Manuel Luque‐Ramírez, Paz de Miguel-Novoa, Eva Fernández-Rodríguez, Irene Halperín, Lourdes Loidi,
The Journal of Clinical Endocrinology & Metabolism

Abstract

The exon 3 deletion in the GHR predicts an improved response to pegvisomant therapy in acromegaly.

References

YearCitations

Page 1